Pfizer Inc - Mar 20, 2023 Form 3 Insider Report for Zura Bio Ltd (ZURA)

Role: 10%+ Owner
Signature: PFIZER INC. By: /s/Susan Grant, Assistant Secretary
Stock symbol: ZURA
Transactions as of: Mar 20, 2023
Transactions value $: $0
Form type: 3
Date filed: 3/30/2023, 06:10 PM
Previous filing: Mar 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Ownership	Footnotes
holding	ZURA	Class A Ordinary Shares, $0.0001 par value						2,970,022	Mar 20, 2023	Direct	F1

Explanation of Responses:

Id	Content
F1	On March 20, 2023, Zura Bio Limited, a limited company incorporated under the laws of England and Wales, JATT Acquisition Corp, a Cayman Islands exempted company ("JATT"), JATT Merger Sub, a Cayman Islands exempted company and wholly owned subsidiary of JATT, JATT Merger Sub 2, a Cayman Islands exempted company and wholly owned subsidiary of JATT, and Zura Bio Holdings Ltd, a Cayman Islands exempted company, consummated the closing of the transactions contemplated by the Business Combination Agreement, dated June 16, 2022, as amended (the "Business Combination Agreement"), pursuant to which the Reporting Person received the reported securities.

Content

On March 20, 2023, Zura Bio Limited, a limited company incorporated under the laws of England and Wales, JATT Acquisition Corp, a Cayman Islands exempted company ("JATT"), JATT Merger Sub, a Cayman Islands exempted company and wholly owned subsidiary of JATT, JATT Merger Sub 2, a Cayman Islands exempted company and wholly owned subsidiary of JATT, and Zura Bio Holdings Ltd, a Cayman Islands exempted company, consummated the closing of the transactions contemplated by the Business Combination Agreement, dated June 16, 2022, as amended (the "Business Combination Agreement"), pursuant to which the Reporting Person received the reported securities.